Take a look around.
Bayer Launches Pulmonary Hypertension Accelerated Bayer (PHAB) Awards to Help Propel Clinical Advancements Forward with up to 1 Million Dollars in Grants
Bayer U.S today announced the launch of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards to support clinical research in pulmonary hypertension (PH), with a focus on pulmonary arterial...Learn more
Bayer presents new analyses for Vitrakvi® (larotrectinib) in adult and pediatric patients with TRK fusion cancer with solid tumors, and new data in primary central nervous system tumors and brain metastases
Bayer today announced findings from new analyses and data for Vitrakvi® (larotrectinib), which is approved for the treatment of adult and pediatric patients with solid tumors that have a...Learn more
Explore Our Divisions
In line with our mission “Bayer: Science for A Better Life,” we aim to improve people’s quality of life.